阿立哌唑配伍利培酮治疗对精神分裂症患者血清MBP、GDNF水平的影响-现代医学

阿立哌唑配伍利培酮治疗对精神分裂症患者血清MBP、GDNF水平的影响

作者：吴慧

单位：扬州五台山医院精神科, 江苏扬州 225000

分类号：R749.3

出版年·卷·期（页码）：2017·36·第十期（1430-1434）

摘要：

目的：探讨阿立哌唑配伍选择性单胺能拮抗剂利培酮治疗对精神分裂症患者血清髓鞘碱性蛋白（MBP）、胶质源性神经营养因子（GDNF）水平的影响。方法：选取2015年6月至2016年6月在我院接受治疗的100例精神分裂症患者，按照随机数字表法分为对照组和研究组各50例。对照组服用利培酮治疗，研究组在对照组基础上服用阿立哌唑。比较两组患者的疗效、认知功能以及血清MBP、GDNF水平。结果：治疗后，两组患者的阳性和阴性症状量表（PANSS）评分均显著降低（P<0.05），且研究组下降幅度较大，两组差异有统计学意义（P<0.05），治疗后两组的认知评分也有明显变化（P<0.05），而治疗组变化幅度更大；研究组治疗后血清MBP水平较治疗前及对照组均有显著下降（均P<0.05），两组患者治疗后的GDNF水平均显著升高，研究组升高幅度显著大于对照组（P<0.05）。结论：阿立哌唑联合利培酮能显著改善精神分裂症患者的精神症状，减轻受损的认知功能，降低MBP水平，提高GDNF水平，为精神分裂症的治疗提供新思路。

Objective: To investigate the effect of aripiprazole combined with selective monoaminergic antagonist risperidone on serum myelin basic protein(MBP) and gGlial cellline-derivedneurotrophic factor(GDNF) in the treatment of schizophrenia patients.Methods: One hundred schizophrenia patients admitted to our hospital from Jun. 2015 to Jun. 2016 were randomly divided into control group and study group with 50 cases in each group. The control group was treated with risperidone, while the study group was treated with aripiprazole in addition to risperidone. The efficacy, cognitive function and serum MBP, GDNF levels were compared between the two groups. Results: After treatment, positive and negative syndrome scale(PANSS) scores of the two groups were both significantly decreased(P<0.05),but the scores in study group decreased more than those in control group with statisticl difference and cognitive scores of the two groups also changed significantly(P<0.05). MBP levels in the study group were lower than those before treatment and those in the control group(P<0.05). After the treatment, the levels of GDNF were increased in the two groups, and the levels in the study group were much higher than those in the control group(P<0.05).Conclusion: Aripiprazole combined with risperidone can significantly improve psychiatric symptoms in patients with schizophrenia, reduce cognitive impairment, decrease the level of MBP and increase the level of GDNF. It can provide new ideas for the treatment of schizophrenia.

参考文献：

[1] 谭庆荣.精神分裂症伴发代谢综合征的处理[J].中华精神科杂志,2014,47(3):172-173.
[2] LLERENA A,BERECZ R,PENAS-LLEDO E,et al.Pharmacogenetics of clinical response to risperidone[J].Pharmacogenomics,2015,14(2):177-194.
[3] 蒋鹏.阿立哌唑与奥氮平治疗精神分裂症患者的疗效和对糖脂代谢影响的对比研究[J].重庆医学,2014,43(1):96-98.
[4] LUTZ D,LOERS G,KLEENE R,et al.Myelin basic protein cleaves cell adhesion molecule L1 and promotes neuritogenesis and cell survival[J].J Biol Chem,2014,289(19):13503-13518.
[5] SUN X L,CHEN B Y,DUAN L,et al.The proform of glial cell line-derived neurotrophic factor:a potentially biologically active protein[J].Mol Neurobiol,2014,49(1):234-250.
[6] 中华医学会精神病学分会.中国精神障碍分类与诊断标准第三版(精神障碍分类)[J].中华精神科杂志,2001,34(3):184-188.
[7] 吴韬,张向荣,唐小伟,等.氯丙嗪和氯氮平维持治疗期精神分裂症患者脑白质完整性比较研究[J].东南大学学报:医学版,2015,34(2):211-217.
[8] 廖金敏,阎浩,刘琦,等.精神分裂症患者认知功能受损和阴性症状的关系[J].中国全科医学,2015,18(30):3666-3670.
[9] EICH T S,NEE D E,INSEL C,et al.Neural correlates of impaired cognitive control over working memory in schizophrenia[J].Biol Psychiat,2014,76(2):146-153.
[10] 张宁,摆翔,蒋犁,等.人脐带间充质干细胞对新生鼠脑白质软化灶的神经保护作用[J].东南大学学报:医学版,2012,31(4):430-435.
[11] 刘亚萍,王晓舟,王萌,等.胶质细胞源性神经营养因子和雌二醇对多巴胺能神经元的协同保护作用[J].解剖学杂志,2014,37(3):335-337,347.
[12] 陈茜,胡嘉波,周朝昀,等.难治性强迫症胶质细胞源性神经营养因子水平与认知功能[J].中国神经精神疾病杂志,2015,41(8):497-500.
[13] 许加军,杨洪安,王国栋.胶质细胞源性神经营养因子对帕金森病大鼠多巴胺能神经元的修复作用[J].山东医药,2014(34):21-23.
[14] MASKEY D,KIM M J.Immunohistochemical localization of brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor in the superior olivary complex of mice after radiofrequency exposure[J].Neurosci Lett,2014,564(2):78-82.

服务与反馈：

【文章下载】【发表评论】【查看评论】【加入收藏】

提示：您还未登录，请登录！点此登录